Superstring Capital Management LP
- SEC CIK
- 0001931118
- Latest filing
- Aug 14, 2026
URGN holding history
UroGen Pharma Ltd. in every 13F filed by Superstring Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
URGN overviewAll 13F holders of URGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 191,313
- Value
- $7.04M
- % of portfolio
- 4.4%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 191,313 | $7.04M | 4.4% | −196,058−50.6% | Reduced | Holders |
| Q1 2026 | 387,371 | $6.96M | 5.0% | −330,983−46.1% | Reduced | Holders |
| Q4 2025 | 718,354 | $16.8M | 9.0% | +630,442+717.1% | Added | Holders |
| Q3 2025 | 87,912 | $1.75M | 1.7% | 00.0% | Unchanged | Holders |
| Q2 2025 | 87,912 | $1.20M | 1.5% | −335,720−79.2% | Reduced | Holders |
| Q1 2025 | 423,632 | $4.69M | 5.6% | +122,426+40.6% | Added | Holders |
| Q4 2024 | 301,206 | $3.21M | 2.8% | +301,206 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −288,267−100.0% | Sold out | Holders |
| Q1 2024 | 288,267 | $4.32M | 2.9% | +32,837+12.9% | Added | Holders |
| Q4 2023 | 255,430 | $3.83M | 2.7% | – | No prior filing | Holders |